[HTML][HTML] Epidermal growth factor receptor inhibition in lung cancer: status 2012
Lung cancer is the most common cause of cancer deaths. Most patients present with
advanced-stage disease, and the prognosis is generally poor. However, with the …
advanced-stage disease, and the prognosis is generally poor. However, with the …
[HTML][HTML] Epidermal Growth Factor Receptor Inhibition in Lung Cancer: Status 2012
FR Hirsch, PA Jänne, WE Eberhardt, F Cappuzzo… - Journal of Thoracic …, 2013 - jto.org
Lung cancer is the most common cause of cancer deaths. Most patients present with
advanced-stage disease, and the prognosis is generally poor. However, with the …
advanced-stage disease, and the prognosis is generally poor. However, with the …
[PDF][PDF] Epidermal Growth Factor Receptor Inhibition in Lung Cancer
FR Hirsch, PA Jänne, WE Eberhardt… - Journal of Thoracic …, 2013 - scholar.archive.org
Lung cancer is the most common cause of cancer deaths. Most patients present with
advanced-stage disease, and the prognosis is generally poor. However, with the …
advanced-stage disease, and the prognosis is generally poor. However, with the …
[PDF][PDF] Epidermal Growth Factor Receptor Inhibition in Lung Cancer
FR Hirsch, PA Jänne, WE Eberhardt, F Cappuzzo - 2013 - researchgate.net
Lung cancer is the most common cause of cancer deaths. Most patients present with
advanced-stage disease, and the prognosis is generally poor. However, with the …
advanced-stage disease, and the prognosis is generally poor. However, with the …
Epidermal growth factor receptor inhibition in lung cancer: status 2012.
FR Hirsch, PA Jänne, WE Eberhardt… - Journal of Thoracic …, 2013 - europepmc.org
Lung cancer is the most common cause of cancer deaths. Most patients present with
advanced-stage disease, and the prognosis is generally poor. However, with the …
advanced-stage disease, and the prognosis is generally poor. However, with the …
Epidermal Growth Factor Receptor Inhibition in Lung Cancer Status 2012
FR Hirsch, PA Janne, WE Eberhardt… - JOURNAL OF …, 2013 - scholarworks.bwise.kr
Lung cancer is the most common cause of cancer deaths. Most patients present with
advanced-stage disease, and the prognosis is generally poor. However, with the …
advanced-stage disease, and the prognosis is generally poor. However, with the …
Epidermal growth factor receptor inhibition in lung cancer: status 2012
FR Hirsch, PA Jänne, WE Eberhardt… - Journal of thoracic …, 2013 - pubmed.ncbi.nlm.nih.gov
Lung cancer is the most common cause of cancer deaths. Most patients present with
advanced-stage disease, and the prognosis is generally poor. However, with the …
advanced-stage disease, and the prognosis is generally poor. However, with the …
[引用][C] Epidermal growth factor receptor inhibition in lung cancer: Status 2012
FR Hirsch, PA Jänne… - … inhibition in lung …, 2013 - produccioncientifica.ucm.es
Epidermal Growth Factor Receptor Inhibition in Lung Cancer: Status 2012.
F Hirsch, P Jänne, W Eberhardt, F Cappuzzo… - 2013 - christie.openrepository.com
Lung cancer is the most common cause of cancer deaths. Most patients present with
advanced-stage disease, and the prognosis is generally poor. However, with the …
advanced-stage disease, and the prognosis is generally poor. However, with the …
Epidermal growth factor receptor inhibition in lung cancer: Status 2012
FR Hirsch, PA Jänne… - Journal of …, 2013 - utsouthwestern.elsevierpure.com
Lung cancer is the most common cause of cancer deaths. Most patients present with
advanced-stage disease, and the prognosis is generally poor. However, with the …
advanced-stage disease, and the prognosis is generally poor. However, with the …